Last edition
News about "OneSource Specialty Pharma"
OneSource-Backed Generic Semaglutide Secures Health Canada Approval
Orbicular and OneSource Specialty Pharma achieve a major milestone with Canada’s second generic Ozempic approval, strengthening their position in global peptide-based injectable markets.
OneSource Specialty Pharma | 04/05/2026 | By News Bureau
OneSource and Orbicular Receive US FDA Tentative Approval for Generic Semaglutide
OneSource and Orbicular secure US FDA tentative approval for generic semaglutide injection, advancing ANDA filing for Ozempic with manufacturing support from OneSource.
OneSource Specialty Pharma | 22/04/2026 | By News Bureau | 165
OneSource Reports INR 47 Crore Net Loss in Q3 FY26 as Revenue Falls 26 Percent
OneSource Specialty Pharma reported a weak performance in the third quarter of FY26, posting a net loss of INR 47 crore for the quarter ended December 31, 2025. The company’s revenue declined 26 percent year on year to INR 290 crore, largely due to delays in converting a key service agreement into a commercial supply contract.
OneSource Specialty Pharma | 27/01/2026 | By Darshana | 196
OneSource Specialty Pharma Strengthens its Board with Key Independent Directors Appointment
The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others.
OneSource Specialty Pharma | 12/03/2025 | By Aishwarya | 576
OneSource Achieves INR 3,926 Million Revenue in Q3FY25
OneSource demonstrated exceptional profitability with EBITDA reaching INR 1,432 million, an 85 percent increase compared to the previous quarter, resulting in a robust EBITDA margin of 36.5 percent, up by 1,334 basis points quarter-on-quarter.
OneSource Specialty Pharma | 01/02/2025 | By Aishwarya | 823
OneSource Unveils New Brand Identity at CPHI Milan
OneSource’s end-to-end offering across all its platforms was established in response to its customers’ need to streamline supply chains by consolidating their outsourcing partners.
OneSource Specialty Pharma | 08/10/2024 | By Aishwarya | 959
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy